ENGINEERED LEUCINE DECARBOXYLASES

    公开(公告)号:US20210238575A1

    公开(公告)日:2021-08-05

    申请号:US17166934

    申请日:2021-02-03

    申请人: Codexis, Inc.

    IPC分类号: C12N9/88

    摘要: The present invention provides engineered leucine decarboxylase (LDC) polypeptides and compositions thereof, as well as polynucleotides encoding the engineered leucine decarboxylase (LDC) polypeptides. In some embodiments, the engineered LDC polypeptides are optimized to provide enhanced catalytic activity, as well as reduced sensitivity to proteolysis, and/or increased tolerance to low pH environments. In some embodiments, the engineered LDC polypeptides are optimized to provide improved storage stability. The present invention also provides methods for the use of the compositions comprising the engineered LDC polypeptides for therapeutic and industrial purposes.

    ENGINEERED LEUCINE DECARBOXYLASES
    5.
    发明公开

    公开(公告)号:US20240018504A1

    公开(公告)日:2024-01-18

    申请号:US18363976

    申请日:2023-08-02

    申请人: Codexis, Inc.

    IPC分类号: C12N9/88

    CPC分类号: C12N9/88 A61K38/00

    摘要: The present invention provides engineered leucine decarboxylase (LDC) polypeptides and compositions thereof, as well as polynucleotides encoding the engineered leucine decarboxylase (LDC) polypeptides. In some embodiments, the engineered LDC polypeptides are optimized to provide enhanced catalytic activity, as well as reduced sensitivity to proteolysis, and/or increased tolerance to low pH environments. In some embodiments, the engineered LDC polypeptides are optimized to provide improved storage stability. The present invention also provides methods for the use of the compositions comprising the engineered LDC polypeptides for therapeutic and industrial purposes.